Related Articles
Hinokitiol inhibits vasculogenic mimicry activity of breast cancer stem/progenitor cells through proteasome‑mediated degradation of epidermal growth factor receptor
Mutational analysis of the insulin‑like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients
EGFR may participate in immune evasion through regulation of B7‑H5 expression in non‑small cell lung carcinoma
EGFR blockade by tyrosine kinase inhibitor or monoclonal antibody inhibits growth, directs terminal differentiation and induces apoptosis in the human squamous cell carcinoma HN5.
Growth and molecular interactions of the anti-EGFR antibody Cetuximab and the DNA cross-linking agent cisplatin in gefitinib-resistant MDA-MB-468 cells: New prospects in the treatment of triple-negative/basal-like breast cancer